Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE® CORAL GABLES, Fla., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (NASDAQ: CPRX), a commercial-stage biopharmaceutical…
Catalyst Pharmaceutical (CPRX) Dips More Than Broader Markets: What You Should Know Catalyst Pharmaceutical (CPRX) closed the most recent trading day at $20.27, moving -0.78% from the previous trading session....…
Zacks Investment Ideas feature highlights: XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB XBI, Catalyst Pharma, Prometheus Biosciences, Sage Therapeutics and IBB are part of the Zacks Investment Ideas article....…